Contralateral R1 in Amyotrophic Lateral Sclerosis - Trial NCT06206629
Access comprehensive clinical trial information for NCT06206629 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospices Civils de Lyon and is currently Recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hospices Civils de Lyon
Timeline & Enrollment
N/A
Feb 15, 2024
Feb 15, 2025
Primary Outcome
Presence of a contralateral R1 component on blink reflex evaluation.
Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting both upper and
 lower motor neurons. Electroneuromyography is an important tool for the diagnosis. Previous
 studies have shown that different components of the blink reflex, such as the latencies of
 homo- and contralateral R2 responses can be affected. Studies have found that a contralateral
 R1 component can appear in neurological diseases with affection of the central nervous system
 especially upper motor neuron, such as HTLV1 infection. Thus, you aim to determine if a
 contralateral R1 component could be present in ALS.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06206629
Non-Device Trial